Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024. In the quarter to June 2026, revenue grew 43.1%, EPS grew 137.5% and free cash flow grew 45.7%, each against the same quarter a year earlier.
Follow OMDA
Omada Health, Inc. (OMDA) Altman Z-score
Omada Health, Inc.'s Altman Z-score for fiscal 2025 is 3.98, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 3.98 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.65 | — | 0.77 | |
| Retained earnings / total assets | (1.50) | — | −2.09 | |
| EBIT / total assets | (0.04) | — | −0.13 | |
| Market value of equity / total liabilities | 7.63 | — | 4.58 | |
| Sales / total assets | 0.85 | — | 0.85 | |
| Altman Z-score | Safe zone | 3.98 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Grey zone | 2.28 | ||
Z and Z″ put Omada Health, Inc. in different zones: safe zone by Z, grey zone by Z″.
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| OMDA Omada Health, Inc. | 4.0× |
| HSTM HealthStream, Inc. compare | 3.5× |
| OMCL Omnicell, Inc. compare | 2.7× |
| CERT Certara, Inc. compare | 2.0× |
| MDRX Veradigm Inc. compare | 1.6× |
| SDGR Schrodinger, Inc. compare | 1.1× |
| PHR Phreesia, Inc. compare | 0.7× |
| GDRX GoodRx Holdings, Inc. compare | 0.4× |
| TDOC Teladoc Health, Inc. compare | −6.7× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets